24
Participants
Start Date
November 14, 2019
Primary Completion Date
April 20, 2020
Study Completion Date
July 13, 2020
HSK3486
HSK3486，Initially 0.4 mg/kg was administered as a 1 minute bolus, followed immediately by a constant infusion dose of 0.4 mg/kg/h administered as a 30 minute infusion via infusion pump.
Phase I Clinical Trial Laboratory, The First Hospital of Jilin University, Changchun
The First Hospital of Jilin University
OTHER
Sichuan Haisco Pharmaceutical Group Co., Ltd
INDUSTRY